FDA Inspection 1002463 — Allergan Pharmaceuticals Ireland
The FDA completed an inspection of Allergan Pharmaceuticals Ireland on December 16, 2016 in Westport. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 16, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Westport (Ireland)
Citations
| ID | CFR | Description |
|---|---|---|
| 1433 | 21 CFR 211.42(c)(10)(iii) | Air Supply |
| 2026 | 21 CFR 211.192 | Quality control unit review of records |